INTRODUCTION
============

*Dioscorea* (Family *Dioscoreacea*) commonly known as yams, are staple foods for Africa, tropical America and Asia. Yams have been traditional consumed as starchy staple food (such as *Dioscorea opposita, Dioscorea alata, Dioscorea japonica*, and *Dioscorea hispida*). The genus *Dioscorea* L. consists of about 630 species distributed all over the world. *Dioscorea hispida* is the most well-known starchy tuber in Malaysia and it is called \`ubi gadong'. Majority of this species contain steroidal saponins with potent pharmacologic activities. Some of *Dioscorea* species being the source of the steroidal sapogenin, diosgenin a precursor for the synthesis of steroidal drugs. The glycoside form of diosgenin is called Dioscin ([@R1]).

Many of the yam tubers are reported to be toxic containing cyanides and have to be detoxified by soaking in flowing water and cooking before consumption in order to remove the toxic compound presents in them ([@R2], [@R3]). However, since traditional detoxified methods are difficult to practice, new dioscorine detoxified equipment was developed to improve the quality and time of detoxified process ([@R4], [@R5]). In terms of therapeutic values, several pharmacological studies have demonstrated that *Dioscin* exhibits anti-tumor ([@R6]), anti-hyperlipidemia ([@R7]), and anti-diabetic ([@R8]) properties. In addition, *D. hispida* extract exhibited significant anti-inflammatory and analgesic properties ([@R9]). The protective effect of *D. alata* however has also been shown previously in aniline-induced splenic toxicity rats due to its antioxidant property and the presence of different phytochemicals ([@R10]). *D. alata* contained alkaloid, flavanoid, saponin, tannin and phenol ([@R11]). In addition, phytochemistry and therapeutic potential of *Dioscorea bulbifera* have been discussed and used in different parts of the world as traditional medicine against several diseases including diabetes, digestive problems, cancer, inflammation and others ([@R12]).

Hepatoxocity is one of the most reported adverse effects caused by herbal products and mechanisms of action leading to toxicity due to the chemical complexity and mixtures of herbal compositions remain vague ([@R13]). *D. hispida* previouslycaused several poisoning symptoms, irregularities and complications to various organs including liver, spleen and kidney in rats([@R14], [@R15]). *Benincasa hispida* aqueous ethanolic extract on the other hand showed survival in both acute and sub-acute toxicity studies in rodents and contain potential therapeutic values ([@R16]). However, to date, alterations of gene expression profiling affecting the liver tissue treated with *D.hispida* have not yet been performed mainly in pregnant rats. Overconsumption of this plant may promote health complications resulting in tissue damage particularly in the liver. This study was carried out to identify the effects of different concentrations of *D.hispida* on liver tissue and to identify the gene expression profiles in pregnant rats using PCR array analysis technique. The identification of steroidal saponins from *D.hispida* have been determined by UHPLC/MS. This information was then used to determine which metabolic and signal transduction pathways were affected following the mechanisms of action involved.

MATERIALS AND METHODS
=====================

Chemical
--------

The steroidal saponins dioscin, protodioscin and prodeltonin were purchased from Chromadex, USA. Acetonitrile and formic acid LCMS grade was purchased from Fisher Scientific (M) Sdn. Bhd (Kuala Lumpur, Malaysia), reverse osmosis Milli-Q water (18.2 MΩ) (Millipore, Billerica, USA) was used for all solutions and dilutions.

Plant samples
-------------

Fresh rhizomes and roots of *D. hispida* were obtained from Machang, Kelantan. Samples were washed, dried and grinded to a powdered form prior extraction with water. Prior to injection (10 mg/mL of dry extract), an adequate volume (ca. 2 mL) was passed through a 0.22 µm PTFE membrane filter.

Analysis of steroidal saponins by UHPLC
---------------------------------------

The liquid chromatographic system was a QExactive UHPLC (Thermo Fischer Scientific, USA) comprised of the following components: binary pump, a solvent degasser, an autosampler, and a thermostatically controlled column compartment. Separation was achieved on WATERS C18 (2.1 × 50 mm, 17 µm) column. The mobile phase consisted of water with 0.1% formic acid (A) and acetonitrile with 0.1% formic acid (B) at flow rate 0.4 mL/min. The following solvent composition was used: 0-5 min, 10-20% B (linear gradient); 5-10 min, 20-60% B (linear gradient); 10-13 min, 60-90 % B (linear gradient); 14-14.10 min, 90-10 % B (linear gradient) and 14.1-15 min, 10% B (isocratic).

Animals
-------

For toxicity study, healthy virgin females and confirmed fertile males (2:1) Sprague Dawley rats with a body weight ranging from 180-200 g and 200-250 g, respectively were obtained from the Animal Resource Unit, Medical Resource Centre, Institute for Medical Research. The animals were housed in polypropylene cages, lined with wood shaving and at controlled temperature (20 ± 2°C), with 40-60% humidity under 12 hours of light and dark cycle. The animals were acclimatized for about a week prior to start of the study. A commercial rat diet (Specialty Feeds, Australia) and water were available *ad libitum*. Ethical approval for this study was obtained from the Animal Care and Ethics Committee, Ministry of Health Malaysia (ACUC No: ACUC/KKM/02 (10/2016).

Experimental design
-------------------

Female rats in the proestrus phase were placed into the cage of males (1:1 basis) in the late morning and left for 24 hours. The vaginal smear was performed on each rat. The mating was confirmed by the presence of sperm and designated as gestation day (GD) 0.

Treatment
---------

The dams were randomly assigned to four treatment groups (Group 1: 250, Group 2: 1000 and Group 3: 2000 mg/kg body weight) and one control group (distilled water) and caged individually. For gene expression analysis, 3 rats were selected from each group. The dams were administered with *D.hispida*aqueous extract once daily by gastric gavage on GD6 to GD20. On GD21 rats were euthanized by carbon dioxide inhalation and caesarean hysterectomy was immediately performed. The liver was removed and immediately stored in RNA later. The samples were kept at -80°C until RNA extraction.

RNA extraction
--------------

A total of 30 mg of each liver tissue was disrupted using a Tissue Ruptor (230V, 50-60Hz, UK) attached with a probe in 600 µl of 1:100 beta-mercaptoethanol in RLT buffer. The samples were then centrifuged for 3 min. The supernatant was collected and mixed with 1 volume of 70% ethanol. All samples were then further processed for total RNA using RNeasy Total RNA Mini Kit (Qiagen) using manufacturer recommended procedures. RNA concentration was measured using Multiskan GO Microplate Spectrophotometer (Thermoscientific, USA).

PCR array analysis
------------------

Gene expression analysis was performed using the PARN 093Z RT^2^ Profiler PCR Array Rat Hepatotoxicity System and Protocol Guide. The Rat Hepatotoxicity PCR Array profiles the expression of 84 key genes implicated as potential biomarkers of liver toxicity. Initially, 100 ng of total RNA sample was converted to cDNA using RT^2^ PreAMP cDNA Synthesis Kit. cDNA was added to RT^2^ qPCR Master Mix and aliquoted across PCR array. The samples were run using Real Time PCR Instrument (StepOnePlus, ABI Biosystem). RT^2^ PCR Data Analysis Software was used for data analysis. Data normalization step was performed. Three housekeeping genes were selected in normalization step known as B2m, Hprt1 and Rplp1 genes. Fold-regulation represents fold-change results in a biologically meaningful way. Fold-change values greater than one indicates a positive- or an up-regulation, and the fold-regulation is equal to the fold-change. Fold-change values less than one indicate a negative or down-regulation, and the fold-regulation is the negative inverse of the fold-change. The p values are calculated based on a Student's t-test of the replicate 2^∧^ (- Delta CT) values for each gene in the control group and treatment groups. The cut-off points for gene array analysis were \>2 fold change with p-value \<0.05.

RESULTS
=======

Ultrahigh performance liquid chromatography liquid chromatography (UHPLC) with MS detection has been used as an efficient tool for sample analysis and to facilitate structural elucidation. In the present study, mass specific detection was employed for identification of steroidal saponin due to its lack of specific chromophore for UV/VIS. Identification was performed using UHPLC-ESI-MS under developed chromatographic condition (Figure [1](#F1){ref-type="fig"}). Compound with a retention time of 11.48 min, produced a strong deprotonated molecule \[M-H\]- (m/z 867.47931) in (-)-ESI-MS. This compound is the main steroidal saponin present in the tuber and was tentatively identified as dioscin with structure molecule as shown in Figure [2](#F2){ref-type="fig"} and Table [1](#T1){ref-type="table"}. Rat Hepatotoxicity RT² Profiler™ PCR Array consists of the most relevant potential biomarkers for five major drug-induced hepatotoxic diseases such as cholestasis, steatosis, phospholipidosis, non-genotoxic hepatocarcinogenicity and necrosis, as well as generalized hepatotoxicity. Using real-time PCR, the expression of selected genes involved in hepatotoxic response with this array can be analyzed. Genes that consistently exhibit increased or decreased expression during these toxic responses in model systems serve as markers to predict potential adverse clinical outcomes.

![Typical UPLC Total ion chromatography (TIC) of plant extract.](IJBS-13-26-g001){#F1}

![Chemical structure and MS spectrum of dioscin in negative ion mode.](IJBS-13-26-g002){#F2}

###### 

Mass spectral characteristic of Dioscin

  Retention time (min)   Compound   Formula     Selected ion   m/z calculated   m/z observed   Error (ppm)
  ---------------------- ---------- ----------- -------------- ---------------- -------------- -------------
                                                                                               
  11.53                  Dioscin    C45H71O16   \[M-H\]-       869.4899         867.47919      6.303

No significant difference was observed at 250 and 1000 mg/kg b.w of *D. hispida* as compared to the control group (Table [2](#T2){ref-type="table"}). However, several genes were significantly down and up-regulated upon treatment with *D.hispida* given at the highest dosage of 2000 mg/kg. Treatment of *D.hispida* at 2000 mg/kg b.w leads to significant upregulation of several genes such as Btg2 (32.22;0.02), Gsr (41.83;0.02), L2hgdn (20.52;0.05), S100a8 (51.28;0.03), Slc17a3 (2.24;0.02), Bhmt (1.85; 0.05), Cd68 (2.19; 0.02), Cyp1a2 (19.91;0.05) whereas several genes were downregulated such as Abcb1a (-29.31; 0.01), Aldoa (-3.45;0.05), Cdc14b (-4.93;0.03), Icam1 (-30.36; 0.02), Krt18 (-5.41; 0.03), Hpn (-4.33; 0.01) and Maob (-2.52; 0.04).

###### 

Fold regulation comparing to the Control group at different concentration of *D. hispida*

  Gene Symbol   Description                                                                                     Fold Regulation (comparing to control group)                                    
  ------------- ----------------------------------------------------------------------------------------------- ---------------------------------------------- ------ --------- ------ -------- ------
                                                                                                                                                                                                
  Abcb11        ATP-binding cassette, subfamily B (MDR/TAP), member 11                                          0.00                                           0.95   -1.83     0.51   4.38     0.38
  Abcb1a        ATP-binding cassette, sub-family B (MDR/TAP), member 1A                                         -2.49                                          0.51   -1.27     0.39   -29.31   0.01
  Abcb4         ATP-binding cassette, subfamily B (MDR/TAP), member 4                                           1.11                                           0.66   -1.09     0.39   -2.02    0.90
  Abcc2         ATP-binding cassette, subfamily C (CFTR/MRP), member 2                                          -1.32                                          0.81   1.74      0.39   1.22     0.36
  Abcc3         ATP-binding cassette, subfamily C (CFTR/MRP), member 3                                          1.50                                           0.47   3.51      0.38   -1.50    0.67
  Aldoa         Aldolase A, fructose-bisphosphate                                                               1.14                                           0.83   6.69      0.38   -3.45    0.05
  Apex1         APEX nuclease (multifunctional DNA repair enzyme) 1                                             2.13                                           0.69   8.25      0.37   -1.70    0.53
  Asah1         N-acylsphingosine amidohydrolase (acid ceramidase) 1                                            1.17                                           0.62   6.86      0.38   -1.18    0.57
  Atp8b1        ATPase, Class I, type 8B, member 1                                                              1.28                                           0.74   15.84     0.37   -1.39    0.57
  Avpr1a        Arginine vasopressin receptor 1A                                                                1.35                                           0.71   25.27     0.37   -1.10    0.73
  Bhmt          Betaine-homocysteine methyltransferase                                                          -1.28                                          0.78   7.70      0.37   1.85     0.05
  Btg2          BTG family, member 2                                                                            8.78                                           0.10   2.65      0.36   32.22    0.02
  Car3          Carbonic anhydrase 3                                                                            -11.84                                         0.24   -46.93    0.18   -4.90    0.84
  Casp3         Caspase 3                                                                                       -1.23                                          0.36   -4.09     0.54   1.78     0.40
  Ccng1         Cyclin G1                                                                                       -2.77                                          0.16   -31.21    0.12   -10.71   0.28
  Cd36          CD36 molecule (thrombospondin receptor)                                                         3.27                                           0.17   13.28     0.37   4.33     0.25
  Cd68          Cd68 molecule                                                                                   1.21                                           0.79   10.98     0.37   2.19     0.02
  Cdc14b        CDC14 cell division cycle 14 homolog B (S. cerevisiae)                                          -1.36                                          0.55   4.68      0.38   -4.93    0.03
  Cdkn1a        Cyclin-dependent kinase inhibitor 1A                                                            -2.08                                          0.45   3.79      0.38   -6.09    0.09
  Col4a1        Collagen, type IV, alpha 1                                                                      -1.07                                          0.43   9.16      0.39   -1.58    0.42
  Cryl1         Crystallin, lambda 1                                                                            -1.81                                          0.41   5.18      0.39   -1.96    0.43
  Cxcl12        Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)                               -1.36                                          0.48   6.18      0.38   -1.46    0.66
  Cyp1a2        Cytochrome P450, family 1, subfamily a, polypeptide 2                                           19.91                                          0.05   18.94     0.37   19.91    0.05
  Ddit4l2       DNA-damage-inducible transcript 4-like                                                          -2.77                                          0.55   1.61      0.38   -1.85    0.57
  Ddx39a        DEAD (Asp-Glu-Ala-Asp) box polypeptide 39                                                       -6.01                                          0.22   -52.24    0.13   -1.29    0.44
  Dnajb11       DnaJ (Hsp40) homolog, subfamily B, member 11                                                    -1.27                                          0.18   -13.59    0.15   2.81     0.38
  Dnajc3        DnaJ (Hsp40) homolog, subfamily C, member 3                                                     -2.82                                          0.09   -8.13     0.48   -8.23    0.61
  Fabp1         Fatty acid binding protein 1, liver                                                             -1.09                                          0.82   6.22      0.37   2.00     0.22
  Fads1         Fatty acid desaturase 1                                                                         -1.24                                          0.66   6.57      0.38   -2.85    0.63
  Emc9          Family with sequence similarity 158, member A                                                   -1.22                                          0.55   7.03      0.37   -5.71    0.15
  Fasn          Fatty acid synthase                                                                             -1.87                                          0.41   6.07      0.38   -2.87    0.39
  Fmo1          Flavin containing monooxygenase 1                                                               27.15                                          0.37   4.60      0.39   -3.16    0.46
  Timm10b       Fractured callus expressed transcript 1                                                         -1.57                                          0.44   7.27      0.38   -1.33    0.59
  Gadd45a       Growth arrest and DNA-damage-inducible, alpha                                                   1186.49                                        0.37   5686.80   0.37   18.32    0.23
  Gclc          Glutamate-cysteine ligase, catalytic subunit                                                    -3.28                                          0.44   -11.74    0.23   7.17     0.42
  Gsr           Glutathione reductase                                                                           9.75                                           0.34   4.31      0.37   41.83    0.02
  Hao2          Hydroxyacid oxidase 2 (long chain)                                                              -46.98                                         0.13   -94.31    0.13   -2.92    0.48
  Hmox1         Heme oxygenase (decycling) 1                                                                    -1.11                                          0.45   -3.51     0.71   -1.04    0.46
  Hpn           Hepsin                                                                                          -4.33                                          0.01   -3.29     0.40   -4.33    0.01
  Hyou1         Hypoxia up-regulated 1                                                                          -1.34                                          0.53   4.31      0.38   -1.07    0.61
  Icam1         Intercellular adhesion molecule 1                                                               35.07                                          0.37   -1.32     0.40   -30.36   0.02
  Igfals        Insulin-like growth factor binding protein, acid labile subunit                                 -2.55                                          0.35   4.56      0.38   -4.01    0.33
  Il6st         Interleukin 6 signal transducer                                                                 -1.53                                          0.42   5.06      0.39   -2.86    0.39
  Ipo4          Importin 4                                                                                      -1.02                                          0.50   14.04     0.38   -1.33    0.49
  Krt18         Keratin 18                                                                                      -4.43                                          0.17   4.26      0.38   -5.41    0.03
  Krt8          Keratin 8                                                                                       8.14                                           0.17   107.66    0.37   13.66    0.20
  L2hgdh        L-2-hydroxyglutarate dehydrogenase                                                              4.78                                           0.36   4.19      0.39   20.52    0.05
  Lgr5          Leucine rich repeat containing G protein coupled receptor 5                                     -2.98                                          0.31   -1.13     0.49   -2.89    0.41
  Lpl           Lipoprotein lipase                                                                              -47.23                                         0.18   1.09      0.38   2.02     0.44
  Lss           Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)                                      -2.65                                          0.14   -3.42     0.91   -1.12    0.45
  Maob          Monoamine oxidase B                                                                             -2.52                                          0.04   -5.19     0.57   -2.52    0.04
  Map3k6        Mitogen-activated protein kinase kinase kinase 6                                                1.47                                           0.54   8.81      0.37   -1.05    0.75
  Mbl2          Mannose-binding lectin (protein C) 2                                                            1.10                                           0.86   4.25      0.38   -12.46   0.43
  Mcm10         Minichromosome maintenance complex component 10                                                 151.55                                         0.37   -1.26     0.98   -3.90    0.12
  Mlxipl        MLX interacting protein-like                                                                    19.18                                          0.37   8.29      0.38   -2.60    0.43
  Mrps18b       Mitochondrial ribosomal protein S18B                                                            1.03                                           0.43   18.50     0.38   1.13     0.45
  Nqo1          NAD(P)H dehydrogenase, quinone 1                                                                -1.08                                          0.60   10.09     0.37   -2.07    0.41
  Nus1          Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)                           1.10                                           0.89   11.43     0.36   -1.16    0.85
  Osmr          Oncostatin M receptor                                                                           27.38                                          0.21   411.08    0.35   13.46    0.17
  Slc51a        Organic solute transporter alpha                                                                1.72                                           0.45   1.47      0.57   -1.00    0.77
  Pdyn          Prodynorphin                                                                                    -4.09                                          0.23   2.53      0.40   -3.41    0.30
  Pla2g12a      Phospholipase A2, group XIIA                                                                    3.09                                           0.13   -4.72     0.87   5.18     0.27
  Ppara         Peroxisome proliferator activated receptor alpha                                                -1.66                                          0.44   1.11      0.48   -3.79    0.10
  Psme3         Proteasome (prosome, macropain) activator subunit 3                                             1.57                                           0.29   10.78     0.37   1.17     0.43
  Pygl          Phosphorylase, glycogen, liver                                                                  -1.53                                          0.47   2.84      0.38   -10.45   0.31
  Rb1           Retinoblastoma 1                                                                                1.69                                           0.75   27.04     0.37   -1.92    0.42
  Rdx           Radixin                                                                                         -1.38                                          0.46   9.09      0.38   -1.97    0.44
  Fam214a       Similar to hypothetical protein MGC38960                                                        7.34                                           0.38   9.01      0.38   -2.10    0.44
  Rhbg          Rh family, B glycoprotein                                                                       -1.26                                          0.44   8.17      0.38   -1.73    0.45
  S100a8        S100 calcium binding protein A8                                                                 11.95                                          0.08   159.15    0.37   51.28    0.03
  Scd1          Stearoyl-Coenzyme A desaturase 1                                                                14.10                                          0.55   209.90    0.36   17.73    0.41
  Serpina3n     Serine (or cysteine) peptidase inhibitor, clade A, member 3N                                    252.30                                         0.14   509.34    0.36   33.40    0.25
  Serpine1      Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1   1.06                                           0.72   55.29     0.37   1.25     0.56
  Skil          SKI-like oncogene                                                                               2.35                                           0.66   -5.11     0.35   2.50     0.52
  Slc17a3       Solute carrier family 17 (sodium phosphate), member 3                                           -1.92                                          0.27   1.99      0.23   2.24     0.02
  Slc2a3        Solute carrier family 2 (facilitated glucose transporter), member 3                             -2.60                                          0.85   13.06     0.37   -1.87    0.68
  Slc39a6       Solute carrier family 39 (zinc transporter), member 6                                           1.55                                           0.86   2.13      0.38   -7.38    0.31
  Srebf1        Sterol regulatory element binding transcription factor 1                                        30.49                                          0.25   33.96     0.16   1.23     0.61
  Tagln         Transgelin                                                                                      -1.17                                          0.46   28.99     0.37   -1.51    0.47
  Thrsp         Thyroid hormone responsive                                                                      -1.99                                          0.40   19.73     0.38   -4.85    0.38
  Tmem2         Transmembrane protein 2                                                                         -1.09                                          0.46   -3.27     0.41   -2.10    0.41
  Txnrd1        Thioredoxin reductase 1                                                                         3.72                                           0.14   80.77     0.37   2.95     0.33
  Wipi1         WD repeat domain, phosphoinositide interacting 1                                                13.15                                          0.14   292.81    0.37   5.00     0.28
  Yrdc          YrdC domain containing (E.coli)                                                                 17.37                                          0.06   42.69     0.33   12.14    0.19

DISCUSSION
==========

Our study showed that the highest dosage of 2000 mg/kg *D.hispida* containing an active compound known as Dioscin caused mortality to the pregnant rats. The PCR Array indicated that several genes were found to be significantly upregulated and downregulated as the concentration of *D.hispida* given to the rats increased. This could possibly explain that the regulations of several gene expressions were affected by different concentrations of *D.hispida* given.

Genes such as Bhmt, Gsr, Slc17a3, Btg2 and Cyp1a2 were upregulated and based on the functional groups, these genes are classified in hepatoxicity group. Cd68 and L2hgdh are known to be involved in necrosis. S100a8 is categorized in phospholipidosis. In addition, several genes were significantly downregulated at the highest dosage and classified into different functional groups; Abcb1a and Icam1 are associated with cholestasis. Hpn is involved in phospholipidosis whereas Maob is associated with hepatoxicity. Aldoa and Krt18 are associated with nongenotoxic hepatocarcinogenicity. Cdc14b is involved in necrosis.

The presence of Dioscin in *D.hispida* may be associated with hepatoprotective effects as shown in previous studies. Dioscin has been shown to have a good protective effect against APAP-induced liver injury and this protective action is related to the regulation of mitochondrial function ([@R17]). In another study, Dioscin exhibited potent effects against liver fibrosis through the modulation of multiple targets and signaling pathways ([@R18]).

Plants containing active compounds such as glucosides, acids or alkaloids are used as medicines, however when taken in excess may lead to several adverse effects ([@R19]). A previous study indicated that administration of *D. hispida* given up to 1250 mg/kg crude extract in rats caused several poisoning symptoms, irregularities and complications to various organs including liver and kidney ([@R15]). However, in another study involving acute and sub-acute toxicity experiments, 50% of *Benincasa hispida* aqueous ethanolic extract given up to 2000 mg/kg to rodents did not cause mortality, behaviour changes and no significant alteration in hematological as well as biochemical parameters results indicating that there is a wide margin of safety for the therapeutic use ([@R16]).

The knowledge of gene expression patterns found in this study has demonstrated practical benefits in terms of predicting pathological events and toxic endpoints. Thus, gene expression data can provide an early indication of toxicity because toxin-mediated changes in gene expression are often detectable before clinical observation, clinical chemistry or histopathology ([@R20]--[@R22]).

CONCLUSIONS
===========

The consumption of *D.hispida* extract containing Dioscin at lower dosage below 2000 mg/kg may not be harmful. In response to administration of *D.hispida* extract given at the highest dosage, the alterations of several genes categorized in different hepatotoxic group functions were observed affecting the liver functions of pregnant rats. The hepatoxicity gene array can be used in developing mechanism-based biomarkers for diagnosis or prognosis of hepatotoxicity-related coagulation abnormalities in the early stage of drug development.
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